3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
18
Neoplasms
18
Breast Neoplasms
16
Colorectal Neoplasms
12
Carcinoma, Non-Small-Cell Lung
11
Lung Neoplasms
10
Urinary Bladder Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Hematopoietic and Lymphatic System Neoplasm
6
Hematologic Neoplasms
6
Ovarian Neoplasms
5
Neoplasm Metastasis
5
Triple Negative Breast Neoplasms
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Mouth Neoplasms
3
Hematopoietic and Lymphoid System Neoplasm
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Renal Cell
3
Sarcoma
2
Radiodermatitis
2
Peritoneal Neoplasms
2
Pathologic Complete Response
2
Parotid Neoplasms
2
Motor Activity
2
Melanoma
2
Malignant Solid Neoplasm
2
Interventions
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Progressive Metastatic Castrate Resistant Prostate Cancer
×
Standard of Care
×
Clear all
NCT07206056
2026-06-03
TulmiSTAR-01
Novartis
Phase 1/2
Recruiting
188 enrolled